Allergy and Infectious Diseases Research in Washington
Allergy and Infectious Diseases Research (93.855) awarded $1.9 billion to recipients in Washington in 564 grants from fiscal 2021 to 2025, 8.7% of the program's national total. Fred Hutchinson Cancer Center received the most, $938 million.
- Awarded in Washington$1.9 billion
- Awards564
- Share of the program8.7%
- Rank among states3rd of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 295 | $511 million |
| FY 2022 | 283 | $494 million |
| FY 2023 | 264 | $307 million |
| FY 2024 | 279 | $265 million |
| FY 2025 | 254 | $319 million |
Recipients in Washington
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Fred Hutchinson Cancer Center | Nonprofits | 86 | $938 million |
| University of Washington | Colleges and universities | 275 | $469 million |
| Benaroya Research Institute at Virginia Mason | Nonprofits | 38 | $223 million |
| Seattle Children's Hospital | Nonprofits | 70 | $157 million |
| Washington State University | Colleges and universities | 32 | $22.4 million |
| Institute for Systems Biology | Nonprofits | 9 | $18.4 million |
| Fred Hutchinson Cancer Research Center | Nonprofits | 3 | $15.1 million |
| HDT Bio Corp | Nonprofits | 9 | $9.8 million |
| Orlance, Inc | Small businesses | 6 | $9.1 million |
| Phase Genomics Inc | Small businesses | 5 | $5.1 million |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to Washington?
$1.9 billion from fiscal 2021 to 2025, across 564 awards. Washington ranks 3rd of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in Washington?
The largest recipient is Fred Hutchinson Cancer Center, with $938 million in 86 awards. Next are University of Washington and Benaroya Research Institute at Virginia Mason.
Can organizations in Washington apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in Washington
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- National School Lunch Program
- Federal Transit Capital Investment Grants
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies